Navigation Links
Treat Your Patients' Pain Effectively
Date:5/15/2008

MONTVALE, N.J., May 15 /PRNewswire/ -- Pain is a chief reason that patients seek medical attention; opioid analgesics are an important option for these patients. Physicians must be able to determine which opioid treatment will provide the best outcomes for their patients.

To make clinicians aware of the importance of choosing the proper opioid analgesic, the dual journals Current Clinical Practice and The Journal of Family Practice: Special Edition Current Clinical Practice have published an online-only supplement in May 2008 titled "Looking beyond the administered drug: Metabolites of opioid analgesics". The supplement, authored by Swati Nagar, PhD, and Robert B. Raffa, PhD, of the Temple University School of Pharmacy, discusses the importance of understanding the active metabolites of opioids, a major cause of adverse events and a key component of an opioid's efficacy and tolerability.

"Looking beyond the administered drug: Metabolites of opioid analgesics" is available on The Journal of Family Practice Website, http://www.jfponline.com/supplements.asp?id=6213 , and on CurrentClinicalPractice.com .

The Journal of Family Practice: Special Edition Current Clinical Practice, an indexed and peer-reviewed journal distributed to 96,000 family physicians, and Current Clinical Practice, distributed to 63,000 doctors of internal medicine, have published this supplement, which was developed by Health Science Communications with support from PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Nurse practitioners and physician assistants can find this supplement on http://www.APCToday.com , an online resource for advanced practice clinicians.

The Journal of Family Practice is published by Dowden Health Media, a Division of Lebhar-Friedman, Inc. APCTODAY is copyrighted by Dowden Health Media, a Division of Lebhar-Friedman, Inc. Dowden Health Media is a full-service healthcare communications company that specializes in high-quality communication with physicians, advanced practice clinicians, and consumers. Its highly respected, peer-reviewed journals reach more than 300,000 physicians and clinicians in surgery, psychiatry, family practice, internal medicine and obstetrics/gynecology.

Web site: http://www.jfponline.com

http://www.dowdenhealth.com

http://www.apctoday.com

http://www.currentclinicalpractice.com


'/>"/>
SOURCE Dowden Health Media
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
5. Free distribution of insecticide-treated mosquito nets can save lives
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
10. Non-medicinal treatment touted for pre-schoolers with ADHD
11. Nonmedicinal treatment touted for preschoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... specializing in medical device compliance and commercialization, has just released a new ... , FDA is more adamant than ever about medical device, pharmaceutical, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of The Garland ... a redesigned website. The new site – still located at http://www.garlandco.com ... and other industry users that Garland serves. , After an ambitious phase of ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Health & Safety Institute (HSI) is offering discounted pricing ... 40-Hour courses from now until November 30, 2017 to assist with the clean-up efforts ... to all businesses and government agencies – whether or not they will be directly ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of ... life. This mouse sets out on a journey that will show that friends are ... creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: